Skip to main navigation Skip to search Skip to main content

A 26-week Study Comparing the Efficacy and Safety of Once-weekly Insulin Icodec and Once-daily Insulin Glargine U100, Both in Combination with Insulin Aspart, in Adults with Type 1 Diabetes

Project: Research

Project Details

StatusActive
Effective start/end date07/22/25 → 12/31/26

Funding

  • Novo Nordisk Incorporated: $81,796.89